Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Chloe E, Atreya"'
Autor:
Nicholas Fidelman, Chloe E. Atreya, Madeline Griffith, M. Alexandra Milloy, Julia Carnevale, Pelin Cinar, Alan P. Venook, Katherine Van Loon
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Extrahepatic disease progression limits clinical efficacy of Yttrium-90 (90Y) radioembolization (TARE) for patients with chemotherapy-refractory metastatic colorectal cancer (mCRC). Trifluridine and tipiracil (TAS-102) has overall
Externí odkaz:
https://doaj.org/article/2d744165fd454412a9fa0371b04c5e54
Autor:
Erin L Van Blarigan, Anand Dhruva, Chloe E Atreya, Stacey A Kenfield, June M Chan, Alexandra Milloy, Iris Kim, Paige Steiding, Angela Laffan, Li Zhang, Sorbarikor Piawah, Yoshimi Fukuoka, Christine Miaskowski, Frederick M Hecht, Mi-Ok Kim, Alan P Venook, Katherine Van Loon
Publikováno v:
JMIR Cancer, Vol 8, Iss 1, p e31576 (2022)
BackgroundWe conducted a pilot 2-arm randomized controlled trial to assess the feasibility of a digital health intervention to increase moderate-to-vigorous physical activity in patients with colorectal cancer (CRC) during chemotherapy. ObjectiveThi
Externí odkaz:
https://doaj.org/article/50ced8a496b643e2afe499c4101d7b48
Autor:
Hannah M. Dragomanovich, Anand Dhruva, Eve Ekman, Kelly L. Schoenbeck, Ai Kubo, Erin L. Van Blarigan, Hala T. Borno, Mikaela Esquivel, Bryant Chee, Matthew Campanella, Errol J. Philip, John P. Rettger, Blake Rosenthal, Katherine Van Loon, Alan P. Venook, Christy Boscardin, Patricia Moran, Frederick M. Hecht, Chloe E. Atreya
Publikováno v:
Global Advances in Health and Medicine, Vol 10 (2021)
Purpose A metastatic cancer diagnosis is associated with high levels of distress in patients and caregivers, which may be alleviated by mindfulness interventions. Research on scalable, tailored, online mindfulness training programs is needed. We soug
Externí odkaz:
https://doaj.org/article/c7915925f8f748679a077124e599447e
Autor:
Jordyn Silverstein, Wesley Kidder, Susan Fisher, Thomas A Hope, Samantha Maisel, Dianna Ng, Jessica Van Ziffle, Chloe E Atreya, Katherine Van Loon
Publikováno v:
Endocrine Connections, Vol 8, Iss 8, Pp 1149-1158 (2019)
Background: Colorectal carcinoma (CRC) during the peri-partum period is challenging to diagnose due to the overlapping symptoms of CRC and pregnancy. This is the first case series to investigate clinicopathologic, hormonal and molecular features of C
Externí odkaz:
https://doaj.org/article/28f0373f46bc476b9319a892a297865a
Autor:
Erin L. Van Blarigan, Hilary Chan, Katherine Van Loon, Stacey A. Kenfield, June M. Chan, Emily Mitchell, Li Zhang, Alan Paciorek, Galen Joseph, Angela Laffan, Chloe E. Atreya, Yoshimi Fukuoka, Christine Miaskowski, Jeffrey A. Meyerhardt, Alan P. Venook
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Over 1.3 million people live with colorectal cancer in the United States. Physical activity is associated with lower risk of colorectal cancer recurrence and mortality. Interventions are needed to increase physical activity in col
Externí odkaz:
https://doaj.org/article/47f55795a9714608bba475e9c67e42bb
Autor:
Ana Ruiz-Saenz, Chloe E. Atreya, Changjun Wang, Bo Pan, Courtney A. Dreyer, Diede Brunen, Anirudh Prahallad, Denise P. Muñoz, Dana J. Ramms, Valeria Burghi, Danislav S. Spassov, Eleanor Fewings, Yeonjoo C. Hwang, Cynthia Cowdrey, Christina Moelders, Cecilia Schwarzer, Denise M. Wolf, Byron Hann, Scott R. VandenBerg, Kevan Shokat, Mark M. Moasser, René Bernards, J. Silvio Gutkind, Laura J. van ‘t Veer, Jean-Philippe Coppé
Publikováno v:
Nature cancer, vol 4, iss 2
Nature Cancer, 4(2), 240-256. Nature Research
Nature Cancer, 4(2), 240-256. Nature Research
BRAFV600E mutation confers a poor prognosis in metastatic colorectal cancer (CRC) despite combinatorial targeted therapies based on the latest understanding of signaling circuitry. To identify parallel resistance mechanisms induced by BRAF–MEK–EG
Autor:
Peter Spanogiannopoulos, Than S. Kyaw, Ben G. H. Guthrie, Patrick H. Bradley, Joyce V. Lee, Jonathan Melamed, Ysabella Noelle Amora Malig, Kathy N. Lam, Daryll Gempis, Moriah Sandy, Wesley Kidder, Erin L. Van Blarigan, Chloe E. Atreya, Alan Venook, Roy R. Gerona, Andrei Goga, Katherine S. Pollard, Peter J. Turnbaugh
Publikováno v:
Nature microbiology, vol 7, iss 10
Pharmaceuticals have extensive reciprocal interactions with the microbiome, but whether bacterial drug sensitivity and metabolism is driven by pathways conserved in host cells remains unclear. Here we show that anti-cancer fluoropyrimidine drugs inhi
Autor:
Eric A. Collisson, AmirAli Talasaz, Pamela N. Munster, Trever G. Bivona, Margaret A. Tempero, Andrew H. Ko, Katherine Van Loon, Robin K. Kelley, Chloe E. Atreya, Zhen Wang, Andrew E. Hendifar, Mary Vu, Jim Leng, Lai Mun Siew, Dragan Sebisanovic, Claire Greene, Oliver A. Zill
Tumor marker levels and cfDNA mutant allele fractions across 19 time intervals for eight patients that were serially monitored via blood draws.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b61b33082c375d2591fee9c8fe16cb14
https://doi.org/10.1158/2159-8290.22530579
https://doi.org/10.1158/2159-8290.22530579
Autor:
Eric A. Collisson, AmirAli Talasaz, Pamela N. Munster, Trever G. Bivona, Margaret A. Tempero, Andrew H. Ko, Katherine Van Loon, Robin K. Kelley, Chloe E. Atreya, Zhen Wang, Andrew E. Hendifar, Mary Vu, Jim Leng, Lai Mun Siew, Dragan Sebisanovic, Claire Greene, Oliver A. Zill
Complete patient-level and mutation-level concordance information, mutation identities, and monitoring status for each patient in study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ab3c361da8b38493344f145b6642aa0
https://doi.org/10.1158/2159-8290.22530582.v1
https://doi.org/10.1158/2159-8290.22530582.v1
Autor:
Eric A. Collisson, AmirAli Talasaz, Pamela N. Munster, Trever G. Bivona, Margaret A. Tempero, Andrew H. Ko, Katherine Van Loon, Robin K. Kelley, Chloe E. Atreya, Zhen Wang, Andrew E. Hendifar, Mary Vu, Jim Leng, Lai Mun Siew, Dragan Sebisanovic, Claire Greene, Oliver A. Zill
Comparisons of CA 19-9 concentration and cfDNA mutant allele fractions in plasma. (A-E) cfDNA mutant allele fractions ("cfDNA percentage") versus CA 19-9 units per milliliter (U/mL) were determined at similar times for five patients with three or mor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19d52df9b18a8acc3ed94d3cccaee290
https://doi.org/10.1158/2159-8290.22530588
https://doi.org/10.1158/2159-8290.22530588